# A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

> **NCT03902600** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 103 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** Moderately Hypofractionated RT

## Key facts

- **NCT ID:** NCT03902600
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-10
- **Primary completion:** 2021-11-11
- **Final completion:** 2026-08-31
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902600, "A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT03902600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*